About Genologics
Genologics is a Healthcare company based in Victoria (Canada) founded in 2002, and was acquired by Illumina in August 2015. Digital LIMS tools are developed for laboratory providers. Genologics has raised $21.96 million across 7 funding rounds from investors including Illumina, Yaletown and GrowthWorks Capital. The company was acqui-hired. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Laboratory Management.
Company details
Genologics was founded in 2002 in Victoria, Canada, within the biotechnology sector. A flagship system named Clarity has been created to support laboratory information management. Features such as workflow management, automation, optimization, reporting, and regulatory compliance are included. Versions tailored for genomics, mass spectrometry, genomic, and clinical laboratories are offered through the companys operations.
- Headquarters Victoria, Canada
- Stage Acquired
- SectorsHealthcare
- Website genologics.com
- Social LinkedIn X Facebook
- Acquired by Illumina (Aug 2015)
Funding Insights of Genologics
Genologics has successfully raised a total of $21.96M across 7 strategic funding rounds. The most recent funding activity was a Series A round of $970.32 thousand completed in September 2013. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $21.96M
- Total Rounds 7
- Last Round Series A — $970,323
- First Round $5M
(Feb 2005)
- Investors Count 4
All 7 funding rounds of Genologics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2013 | $970,323 | Series A | – | – | – |
| Mar 2013 | $1.77M | Series A | – | – | – |
| Oct 2011 | $8M | Series A | – | Illumina | – |
| May 2010 | $1M | Series A | – | – | – |
| Apr 2009 | $1.22M | Series A | – | – | – |
| Feb 2009 | $4M | Series A | – | GrowthWorks Capital, OVP Venture Partners | |
| Feb 2005 | $5M | Series A | – | Yaletown, OVP Venture Partners | – |
4 investors in total: 4 institutional.
Investors in Genologics
Genologics has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include Illumina, Yaletown and GrowthWorks Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Technology investments are made to drive transformative industry growth. | yaletown.com | Vancouver, Canada | ||
Stage-agnostic sector-agnostic VC firm investing in Canada and the US | growthworks.ca | Vancouver, Canada | ||
Early-stage VC investments are focused primarily on US companies. | ovpevents.com | Seattle, United States | ||
Developer of technologies for analysis of genetic variation and function | 1993 | illumina.com | San Diego, United States |
Investor details for Genologics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Genologics
4 dated milestones of Genologics across 13 years, from founding to its latest funding, stage changes and deals.
- Founded Genologics is founded.
- Funding First funding round of $5.0M.
- Funding Latest funding round, Series A, of $970K.
- Exit Acquired by Illumina.
Web traffic of Genologics
Websites that share an audience with Genologics (genologics.com).
Websites whose visitors overlap most with Genologics. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| genelogic.com | 100% | View details | |||
| bioinquire.com | 89% | View details | |||
correlogic.com | correlogic.com | 89% | – | ||
limsource.com | limsource.com | 87% | – | ||
| agilebio.com | 86% | #11,355,691 | View details |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Genologics
Complete news archive for Genologics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Genologics
Genologics was founded in 2002 and raised its 1st funding round 3 years after it was founded.
Genologics is headquartered in Victoria, Canada. It is registered at Victoria, British Columbia, Canada.
Genologics is a funded company, having raised a total of $21.96M across 7 funding rounds to date. The company's 1st funding round was a Series A of $5M, raised on Feb 2005.
Genologics was founded in 2002 in Victoria, Canada, within the biotechnology sector. A flagship system named Clarity has been created to support laboratory information management. Features such as workflow management, automation, optimization, reporting, and regulatory compliance are included. Versions tailored for genomics, mass spectrometry, genomic, and clinical laboratories are offered through the companys operations.
Genologics has 4 investors. Key investors include Illumina, Yaletown, GrowthWorks Capital, and OVP Venture Partners.
Yes. Genologics was acquired by Illumina in August 2015.